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A B S T R A C T   
Increasing evidence points to inflammation as a key factor in the pathogenesis of diabetic retinopathy (DR). 
Choroidal changes in diabetes have been reported and several attempts were made to validate in vivo choroidal 
thickness (CT) as a marker of retinopathy. We aimed to study choroidal and retinal changes associated with 
retinopathy in an animal model of spontaneous Type 2 diabetes, Goto-Kakizaki (GK) rats. Sclerochoroidal whole 
mounts and cryosections were prepared from 52-week-old GK and age-matched control Wistar Han rats. CT was 
measured by optical coherence tomography. Microglia reactivity, pericyte and endothelial cells distribution, and 
immunoreactivity of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2) were evaluated 
by immunofluorescence. Choroidal vessels were visualized by direct perfusion with 1,1’-dioctadecyl-3,3,3’,3’- 
tetramethylindocarbocyanine perchlorate (Dil). Choroidal vascular density was evaluated by fluorescence mi-
croscopy. GK rats had increased CT (58.40 ± 1.15 μm versus 50.90 ± 1.58 μm, p < 0.001), reduced vascular 
density of the choriocapillaris (CC) (p = 0.045), increased Iba1+ cells density in the outer retina (p = 0.003) and 
increased VEGFR2 immunoreactivity in most retinal layers (p = 0.021 to 0.037). Choroidal microglial cells and 
pericytes showed polarity in their distribution, sparing the innermost choroid. This cell-free gap in the inner 
choroid was more pronounced in GK rats. In summary, GK rats have increased CT with decreased vascular 
density in the innermost choroid, increased VEGFR2 immunoreactivity in the retina and increased Iba1+ cells 
density in the outer retina.   
Abbreviations: AGE, advanced glycation end-product; BRB, blood-retinal barrier; CC, choriocapillaris; CT, choroidal thickness; DAPI, 4’,6-diamidino-2-phenyl-
indole; Dil, 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate; DME, diabetic macular edema; eNOS, endothelial nitric oxide synthase; DR, diabetic 
retinopathy; EDI, enhanced deep imaging; GCL, ganglion cell layer; GK, Goto-Kakizaki; HbA1c, hemoglobin A1c; Iba1, ionized calcium binding adapter molecule 1; 
INL, inner nuclear layer; IPL, inner plexiform layer; MHC II, major histocompatibility complex II; NG2, neural-glial antigen 2; OCT, optical coherence tomography; 
OCTA, optical coherence tomography angiography; OLETF, Otsuka long-Evans Tokushima fat; ONH, optic nerve head; ONL, outer nuclear layer; OPL, outer plexiform 
layer; PBS, phosphate buffer saline; PFA, paraformaldehyde; RAAS, renin-angiotensin-aldosterone system; RECA-1, rat endothelial cell antigen 1; RPE, retinal 
pigment epithelium; SD-OCT, spectral domain optical coherence tomography; SDT, spontaneously diabetic Torii; SEM, standard error of the mean; T1D, Type 1 
diabetes; T2D, Type 2 diabetes; VEGF, vascular endothelial growth factor; VEGFR2, vascular endothelial growth factor receptor 2. 
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1. Introduction 
Type 2 diabetes (T2D) accounts for more than 90 % of all cases of 
diabetes and is related, mostly, with age, sedentary life and diet overload 
[1]. Diabetic retinopathy (DR) and its complications are commonly 
treated with anti- vascular endothelial growth factor (VEGF) agents [2] 
and the greater focus has been put on the role of VEGF on the patho-
genesis of DR [3,4]. VEGF-driven inner blood-retinal barrier (BRB) 
breakdown in the venule side of the superficial retinal vasculature has 
been pointed as the earliest event in DR [3] and it was related to pericyte 
loss and hypoxemia [5]. Nevertheless, VEGF is not increased in the 
vitreous of all patients with diabetic macular edema (DME), while 
proinflammatory markers were found to be increased [6]. Accordingly, 
about one third of patients with DME fail to respond to anti-VEGF 
therapy [7]. Those facts pointed DR to be an inflammatory condition 
and that was confirmed experimentally [8,9]. The retinal resident innate 
immune system, which is primarily composed of tissue-resident mac-
rophage-like microglial cells, become activated and start to produce 
proinflammatory mediators [9]. The perspective of DR as an inflam-
matory disease brought new attention on previous works describing 
choroidal inflammatory alterations in diabetes, named as ‘diabetic 
choroidopathy’, including Bruch’s membrane deposits and increased 
thickness, and choriocapillaris (CC) dropout [10,11]. Since the advent of 
optical coherence tomography (OCT), the choroidal thickness (CT) has 
been sought as a surrogate of choroidal flux, diabetic choroidopathy or 
DR, but the results are conflicting and disappointing [12–15,20]. Recent 
works did not unveil the contradictions. The CT was found to be 
decreased [16–21], increased [15,22], or unchanged [14,23] in T2D 
patients. More recently, it was reported that the CT increased in the 
early stages of DR, and further decreased with DR progression [24]. The 
thinning of the choroid with the anti-VEGF treatment of DME increased 
the assumption that the choroid thickens in DR and DME in an 
VEGF-dependent exclusive manner [13]. Nevertheless, the thinning of 
the choroid under anti-VEGF treatment seems to be only a side effect, 
with poor prognostic value [25], focusing back the attention on cellular 
and molecular signatures that might take place in diabetic choroidop-
athy. Indeed, the water homeostasis in the retina and in the choroid 
depend on different cell types. Retinal water clearance at the choroid 
level depends on the oncotic pressure underneath the retinal pigment 
epithelium (RPE), developed by the existence of VEGF-dependent pores 
in the CC [26]. However, anti-VEGFs were found to decrease such pore 
number [27]. The thickening-back of the choroid in DME, when the 
anti-VEGF effect subsides, may not necessarily be related to the water 
homeostasis in the retina, but to reversible vasoconstriction [28,29]. 
Several animal species, mostly rodents, have been used as validated 
models for diabetes and to study the cellular and molecular aspects of 
the pathogenesis of DR [30,31]. Animal models of T2D include: i) obese 
animal models, such as Lepob/ob mice, Leprdb/db mice, Zucker diabetic 
fatty rats, Otsuka long-Evans Tokushima fat (OLETF) rats [31], as well as 
high fat feeding [32]; and ii) nonobese animal models, such as 
Goto-Kakizaki (GK) rats and spontaneously diabetic Torii (SDT) rats [30, 
31]. The GK rats are one of the most useful animal models for studying 
the pathophysiologic progress of T2D and its complications, namely 
retinopathy, as formerly published articles in our institute showed [33, 
34]. GK rats are a lean model of T2D, which is characterized by early and 
relatively stable mild hyperglycemia, hyperinsulinemia, and insulin 
resistance [31]. Moderate diabetic condition allows for prolonged dis-
ease in GK rats, similarly to what is observed in humans. GK rats also 
present some features found in patients with DR and thus they are a 
model to study the kinetics and events of T2D. Increased NO production, 
early inner BRB breakdown and migration of activated microglial cells 
from the retina to the choroid by transcytosis has been demonstrated in 
GK rats [34–36], but the breakdown of the outer BRB and Bruch’s 
membrane permeability in diabetes is not completely understood yet 
[37]. 
We investigated the impact of T2D on the CT and choroidal vascular 
density, as well as on endothelial cells and pericytes, microglial cell 
reactivity, VEGF and VEGF-receptor 2 (VEGFR2) immunoreactivity, in 
the retina and choroid of GK (52 weeks old, 52 W) and age-matched 
control Wistar Han rats. 
2. Materials and methods 
2.1. Animals 
Male spontaneously diabetic GK rats were obtained from the Faculty 
of Medicine of University of Coimbra breeding colony established in 
1995 with breeding couples from the colony at the Tohoku University 
school of Medicine (Sendai, Japan; courtesy of Dr. K. I. Susuki). Control 
animals were age-matched non-diabetic male Wistar rats, obtained from 
our local colony at the Coimbra Institute for Clinical and Biomedical 
Research (iCBR). Animals were housed in the certified animal facility at 
iCBR, on a 12 h light/12 h dark cycle, at 22− 23 ◦C, and 60 % relative 
humidity, and with free access to water and to rodent standard main-
tenance chow (4RF21, Mucedola s.r.l., Settimo Milanese, Italy) con-
taining 18.5 % of protein and 3.0 % of lipids. Animals further got 
shredded paper and cardboard rolls for nest building and shelter. All 
procedures were approved by the Animal Welfare Committee of the 
Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty 
of Medicine, University of Coimbra. The animals received humane care 
according to the criteria outlined in the Guide for the Care and the Use of 
Laboratory Animals prepared by EU Directive 2010/63/EU for animal 
experiments and with the Association for Research in Vision and 
Ophthalmology (ARVO) statement for animal use. At 52 W, the animals 
(n = 12, control group; n = 16, GK group) were weighted and glycemia 
was measured using a glucometer (Ascensia ELITE™, Bayer Corpora-
tion, Mishawaka, IN, USA). 
2.2. Optical coherence tomography 
The animals were anesthetized via i.p. injection with ketamine 80 
mg/kg + xylazine 5 mg/kg (80:5, for short; Imalgene 1000, Merial, 
Lyon, France, and Rompum®, Bayer, Leverkusen, Germany, respec-
tively), and cornea anesthesia (4 mg/mL oxybuprocaine hydrochloride; 
Anestocil®, Laboratório Edol, Carnaxide, Portugal), pupils dilation (1 %, 
Tropicil®, Laboratório Edol, Carnaxide, Portugal) and corneal hydration 
(2 % Methocel™, Dávi II Farmacêutica S.A., Barcarena, Portugal) was 
kept during procedure. 
The CT was evaluated in the animals using spectral domain optical 
coherence tomography (SD-OCT) at 52 W. The SD-OCT system is able to 
capture 10,000–20,000 A scans per second with an axial resolution of 2 
μm and a transverse resolution of 4 μm. OCT was performed in both eyes 
of all animals at 52 W, just before being euthanized. The 830 nm SD-OCT 
Imagine System (Phoenix Micron IV, Phoenix Research Labs, Pleas-
anton, CA, USA) [38] was placed closer to the eye such that an inverted 
image was obtained and the deeper structures were placed closer to 
zero-delay [39]. Scans were obtained superior to the optic nerve 
head/optic disc (ONH), in both eyes of all animals, in the area within 
1–3 ONH diameter from the optic disc. For each location, the device 
collected a set of 1024 raster scans along the scan length. Upon collec-
tion, a set of five images was converted into a single image to reduce the 
noise observed on individual images. The CT was measured using 
InSight image segmentation software (v.1, Voxeleron LLC - Image 
analysis solutions, Chabot Drive, CA, USA). An average of three inde-
pendent scores obtained from 3 sets “five frames averaged” was used as 
the CT value per eye per time-point. 
2.3. Tissue preparation for cryosections 
The animals were anesthetized, as described above, and intracardi-
ally perfused with 0.1 M phosphate buffer saline (PBS, 137 mM NaCl, 2.7 
mM KCl, 1.8 mM KH2PO4, 10 mM Na2HPO4, pH 7.4), followed by 4 % 
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paraformaldehyde (PFA) in 0.1 M PBS, pre-warmed at 37 ◦C. 
The enucleated eyes of GK (n = 8) and age-matched control Wistar 
Han (n = 5) rats were post-fixed in 4% PFA for 1 h. The eyes were 
washed in successive solutions of PBS and immersed in solutions con-
taining 15 % and 30 % of sucrose in PBS, for 1 h in each solution. They 
were embedded in a 1:1 30 % sucrose and embedding resin (Shandon™ 
Cryomatrix™, Thermo Fisher Scientific, Waltham, MA, USA) solution, 
before freezing in dry ice. The samples were stored at -80 ◦C, until 
further use. Eyeball sections 14 μm-thick from both right and left eyes 
were obtained using a cryostat (Leica CM3050S, Nussloch, Germany), at 
-22 ◦C, and mounted on adhesive slides (Superfrost Plus™, Thermo 
Fisher Scientific). A total of four sections (14 μm apart) were collected 
per slide. 
2.4. Immunofluorescence 
Eye sections were labeled to assess the retinal and choroidal struc-
ture, following a procedure described previously [40]. The cryosections 
were rehydrated twice in PBS for 5 min, followed by blocking and 
permeabilization for 1 h in 10 % goat serum and 0.5 % Triton X-100 in 
PBS. The sections were then incubated overnight with primary anti-
bodies (Table S1) diluted in 0.5 % Triton X-100, at 4 ◦C. After washing 
with PBS, sections were incubated with corresponding secondary anti-
bodies (Table S2) diluted in 0.5 % Triton X-100, for 1 h. After washing, 
the sections were incubated with 1:5,000 4’,6-dia-
midino-2-phenylindole (DAPI, Invitrogen™), and coverslipped using 
mounting medium (Glycergel, Dako, Carpinteria, CA, USA). 
Digital images were captured using an inverted fluorescence micro-
scope (Axio Observer.Z1, Zeiss, Carl Zeiss Meditec AG, Jena, Germany) 
and a laser scanning confocal inverted microscope (LSM 710 Axio 
Observer, Zeiss), using objectives “Plan-Apochromat” 20×/0.8 (Zeiss). 
Eight bit images were analyzed using the ImageJ software (version 
1.48, National Institutes of Health, USA) [41]. Iba1+ and MHC II+ cells 
were manually counted in the choroid and retina. Data were expressed 
as number of cell/mm of choroidal or retinal length, respectively. Rat 
endothelial cell antigen 1 (RECA-1) and the neural-glial antigen 2 (NG2) 
immunoreactivities were scored in the choroid as fluorescence intensity 
per area selected (reference area selected of 10,737.08 ± 6,306.11 μm2), 
while fluorescent NG2+ cells and RECA-1 focal immunostaining were 
manually counted in the retina. VEGF and VEGFR2 immunoreactivity 
was quantified as fluorescence intensity/area for each layer analyzed. 
All results were expressed as the mean count of 12 slices per eye (right 
eye only). 
2.5. Direct labeling and visualization of choroidal vessels in 
sclerochoroidal whole mounts 
Intracardiac perfusion with PBS was performed in rats (n = 7, control 
group; n = 8, GK group) under anesthesia (i.p.; ketamine:xylazine 
160:30). Dil (Cat. #D-282, Invitrogen™, Carlsbad, CA, USA) 0.120 mg/ 
mL in 1 % glucose in PBS was applied via cardiac perfusion, following 
perfusion with 4 % PFA. The eyes were enucleated, and choroidoscleral 
whole mounts were prepared. The whole mounts were fixed in 4 % PFA 
for 15 min, washed with PBS, and blocked with 10 % goat serum in 0.3 
% Tween in PBS for 1 h. Samples were incubated with the primary an-
tibodies diluted in 3 % goat serum in PBS for 3 days at 4 ◦C (Table S1). 
After washing overnight with PBS, whole mounts were incubated with 
secondary antibodies (Table S2) overnight at 4 ◦C. After washing, 
samples were flat mounted onto glass slides using mounting medium. 
The images were obtained by laser scanning confocal microscope LSM 
710 (Zeiss), using an objective EC “Plan-Neofluor” 40×/1.30 Oil M27 
(Zeiss). A series of z-stacks were captured from the RPE outer surface, to 
the outer choroid. Each z-stack consisted of a depth of optical sections, 3 
μm apart, along the z-axis. Iba1+ and MHC II+ cells were classified as 
ramified or round cells and were manually counted in the choroid in all 
in-depth planes of the slide (Fig. S1). The choroidal vascular density 
(defined as the percentage of total area covered by CC vessels) [42] was 
determined from independent z-stacks collected at ≤ 10 μm (CC) and >
10 μm outwards from the RPE plane (medium and large vessels) in a 
selected area (213 × 213 μm, Fig. S2). Results were expressed as the 
mean of 14 counts per eye. 
2.6. Statistical analysis 
The statistical analysis was performed using SPSS (Version 25.0, IBM 
Corp., Armonk, NY, USA). The Shapiro-Wilk test was used to assess the 
normality of data (p > 0.05). The normally distributed data were eval-
uated concerning the homogeneity of variance, using the Levene’s test (p 
> 0.05). The independent t-test was used to compare the means between 
two experimental groups for the same variable. Statistical significance 
was defined as p < 0.05. Values were presented as mean ± standard 
error of the mean (SEM). 
3. Results 
3.1. Diabetic animals exhibit decreased body weight and hyperglycemia 
A total of 28 animals (52 W) were enrolled in the study (16 GK and 
12 age-matched control Wistar Han rats). The weight of GK rats was 
significantly lower than that of age-matched control rats (416.31 ± 7.0 g 
and 462.5 ± 9.24 g, respectively, p < 0.001) and glycemia was signifi-
cantly higher (227.75 ± 12.1 mg/dL versus 107.0 ± 0.94 mg/dL, p <
0.001, Fig. S3). 
3.2. Increased choroidal thickness in GK rats 
CT was assessed in both eyes of all GK (n = 32 eyes) and age-matched 
control Wistar Han (n = 24 eyes) rats at 52 W, using OCT. CT was higher 
in GK rats (58.40 ± 1.15 μm versus 50.90 ± 1.58 μm, p < 0.001, Fig. 1A 
and B). 
3.3. Choroidal blood vascular density is reduced in the inner choroid in 
GK rats 
Fifteen animals (8 GK and 7 age-matched control Wistar Han rats) 
were assigned to perfusion with Dil and sclerochoroidal whole mounts 
were prepared and assessed by confocal microscopy. 
The choroidal vascular density in the innermost choroid/ CC (≤ 10 
μm) was significantly decreased in GK rats (p = 0.045, Fig. 2A and C and 
Table S3). Choroidal Iba1+ and MHC II+ cell number was not signifi-
cantly different between GK and age-matched control rats (Fig. 2B and D 
and Table S4). 
Interestingly, Iba1+ cells and MHC II+ cells topographic disposition 
in the choroid spare the innermost choroid, where they are notably rare 
or absent, being preferentially present in the middle and outer choroidal 
stroma, either in GK or age-matched control rats (Videos S1-6). 
3.4. Increased immunoreactivity of microglial cell markers in the outer 
retina of GK rats 
Iba1+ cells increased in the retina of GK rats, being statistically 
significantly increased in the outer plexiform layer (OPL, t(11.000) =
-3.872, p = 0.003). Iba1+ (p = 0.195) and MHC II+ cells density was not 
statistically significantly different in the choroid of GK rats (t(11.000) =
2.190, p = 0.051, Fig. 3 and Table S5). Interestingly, Iba1+ cells were 
distributed throughout the retina of GK rats paralleling the topographic 
distribution of the 3 vascular plexuses of the retina. Iba1+ cell extensions 
from the inner plexiform layer (IPL) to the OPL resemble the commu-
nications between the deep and middle vascular plexuses of the retina, 
suggesting that migrating glial cells towards the outer retina may use the 
communicating inter-plexuses retinal capillaries as a scaffold (see 
Fig. 3A, bottom left panel). Communications between plexus were 
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evidenced. 
3.5. Pericytes are rare in the innermost choroid of GK rats 
There were no statistically significant differences in the immunore-
activity of NG2 and RECA-1 between GK and age-matched control 
Wistar Han rats, whatever the location considered (Fig. 4 and Table S6). 
Nevertheless, there was a trend to increased NG2 immunostaining in the 
choroid of GK rats. Combined immunoreactivity of RECA-1 and NG2 
evidenced a rarefaction of pericytes in the innermost choroid of GK rats. 
RECA-1 co-localized with the CC layer, just underneath and in close 
continuity with the RPE cell plane (Fig. 4A, left panels). NG2 immuno-
reactivity was absent in some areas of the CC plane, leaving fluorescent- 
free gaps between the RPE and the inner choroid, drawing a typical 
jagged pattern, corresponding to the absence of pericytes/mural cells in 
the innermost choroid (Fig. 4A, middle panels, blue arrows). This ‘po-
larity’ in choroidal vascular regulatory cells disposition evidenced by 
NG2, corresponding to a rarefaction of pericytes in the innermost 
choroid, was more evidenced in GK rats. The three retinal plexuses 
(superficial, in the retinal nerve fiber and ganglion cell (GCL) layers; 
middle, in the IPL and deep, in the OPL) were visualized by RECA-1 
immunolabeling (Fig. 4A, top panels, left and right). 
3.6. VEGFR2 immunoreactivity was significantly increased in GK rats 
VEGF immunoreactivity was more intense in the level of the OLM, 
RPE and choroid, while VEGFR2 immunoreactivity was negligible at 
those locations. VEGFR2 immunoreactivity was more intense in the 
inner retina. Higher VEGFR2 immunoreactivity was observed in GK rats, 
significantly in the IPL, INL, OPL, ONL and OLM, when comparing with 
age-matched control rats (Fig. 5 and Table S7). 
4. Discussion 
CT has been searched as a surrogate of DR, DME, choroidal flux and 
diabetic choroidopathy in T2D patients, but contradictory results have 
been reported [12–15,20]. Although GK rats are not blueprints for the 
diseased T2D humans, they provide excellent insights into the patho-
genesis of T2D [43]. Furthermore, rats are recognized as the preeminent 
model for studying the choroid [44,45]. We found that CT was signifi-
cantly increased in GK rats when comparing with age-matched control 
Wistar Han rats. To our knowledge, this is the first time that the CT is 
assessed in vivo in a rat model of T2D. 
The vascular density was reduced in the inner choroid of GK rats, 
corresponding to the CC. This observation is in accordance with CC 
degeneration observed in T2D humans, either by postmortem specimens 
or by OCT-angiography (OCTA) [11,46]. OCTA binarization technique 
in human diabetics showed results of decreased flow or depletion at the 
CC level that agree with our results in the animal [47]. The findings of no 
significant difference in the outer choroid’s vascular density combined 
with a significantly higher CT in GK rats, enhances the role of the outer 
choroid layer, the suprachoroid, as an important contributor to total CT 
and may explain why available data on human CT are so contradictory 
[13–15,48,49]. The suprachoroid is the choroidal layer most prone to 
change, but it is the most difficult to evaluate correctly when not using 
high definition devices such as the Swept Source OCT and the high 
resolution mode enhanced deep imaging (EDI) of the SD-Spectralis OCT 
[12,25]. Unfortunately, devices based on red blood cells’ movement as 
the OCTA are not expected to help much in this issue either [50]. 
The normal distribution of inflammatory cells in the choroidal 
stroma, sparing the innermost choroid, suggests that under inflamma-
tory stress a dramatic increase in the number of inflammatory cells may 
result in packing of cells at this area, leading to disturbances of the 
photoreceptors/RPE/Bruch’s membrane/CC tapetoretinal unit (S1-3 
Videos) [51]. Nevertheless, we did not find inflammatory cells to be 
significantly increased in the choroid of GK rats. It is possible that this 
finding correlates with the low level of diabetes in this animal model. 
Actually, we found increased inflammatory cells in the choroid of a more 
aggressive diabetic animal model, streptozotocin-induced Type 1 dia-
betes (T1D) [52]. The number of inflammatory cells were increased in 
the retina, as previously described, mainly in the OPL [9,36]. Interest-
ingly, Iba1+ cells disposition parallels the three retinal plexuses’, and 
the migration of cells from the inner to the outer retina resembles the 
capillary communications between plexuses, suggesting that vessels are 
a scaffold for cell migration. 
The VEGF levels were not significantly increased in the retina, RPE or 
choroid, in GK rats. VEGFR2 expression was negligible in the RPE or 
choroid both in GK and age-matched control Wistar Han rats. 
Fig. 1. Choroidal thickness (CT) of GK and age-matched 
control Wistar Han rats (52 W). (A) Images resulting from 
five frames averaged, collected as inverted images using OCT 
raster scans obtained in 1024 continuous points, by 
approaching the device to the zero delay line. Horizontal raster 
scan line encompasses an area within 1 to 3 disc diameters 
from the optic nerve head. Choroidal layer obtained by auto-
matic segmentation was manually corrected. A mean of three 
independent scores obtained from 3 different located sets “five 
frames averaged” were used as the CT value per eye per time- 
point. (B) CT values from all eyes of GK (n = 32) and age- 
matched control (n = 24) rats. Data are expressed as mean ±
SEM. Scale bar: 100 μm. Significance between groups was 
determined using the independent t-test: ***p < 0.001. GCL, 
ganglion cell layer; INL, inner nuclear layer; ONL, outer nu-
clear layer; RPE, retinal pigment epithelium.   
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Conversely, VEGFR2 immunoreactivity peaked in the retinal nerve fiber 
layer of both GK and control rats, and it was increased throughout the 
retina of GK rats. The precise cellular background for this increased 
expression is not clear, but the combination of maximum expression in 
the innermost retina and expression throughout the retina resembles the 
distribution of Müller cells and neurons within the retina. Nevertheless, 
a previous report in an animal model of T1D showed VEGFR2 to be 
expressed mainly in the capillaries of the retina and, in opposition to our 
findings, in the CC [53]. Conversely, other data correlated VEGFR2 more 
strikingly with neurons and Müller cells rather than with endothelial 
cells [54]. Interestingly, the VEGFR2 expression by neurons and Müller 
cells combined with the action of MHC II+ cells, was related with 
capillary vertical sprouting and the formation of the deep retinal plexus, 
an example of neurovascular crosstalk or coupling. The relationship 
between increased VEGFR2 and normal VEGF immunoreactivity is not 
clear, if any at all. If that results from a milder diabetes in our model, 
VEGFR2 would be among the first molecular biomarkers to change in 
DR. However, this datum needs to be confirmed in future studies. 
Disposition of pericytes in the CC was previously described in mice to 
be at its scleral side only (polarized distribution) and focal pericyte 
depletion has been related to vascular remodeling [55]. We found dis-
tribution of NG2+ cells in the innermost choroid to draw a jagged 
pattern, when comparing with RECA-1 endothelial immunostaining. 
These focal ‘gaps’, suggesting the existing of cell-free spaces in the 
innermost choroid, may be related to vascular remodeling of the CC and 
not necessarily to permanent alterations, and were more pronounced in 
T2D. Interestingly, this disposition is shared by stromal Iba1+ cells in the 
same location (S1− 6 Videos). Reduction of the vascular component of 
the diabetic CC reported in OCTA studies did not separate permanent 
degenerative from transient and reversible changes, mirroring increased 
CC remodeling in diabetes reported in postmortem studies in humans 
and in rats [11,49,50,56]. Increased remodeling of the CC, probably 
mediated by abluminal pericytes contacting the endothelium as 
peg-in-socket or tongue-in-socket processes, may be an adaptation to the 
pore kinetics, water load, ionic and pH alterations, VEGF levels and the 
presence of inflammatory mediators and cells in the diabetic choroid 
[55,57]. OCTA, being able to resolve the microvascular network of the 
retina and nonperfusion areas at the CC, does not evaluate hitherto 
Fig. 2. Vascular and cell profiles of the choroid of GK and age-matched control Wistar Han rats (52 W). (A) Representative images of vascular density in the 
inner choroid (≤ 10 μm). (B) Choroidal Iba1+ and MHC II+ cells. Ramified cells (green arrows) and round cells (red arrows) were highlighted. (C) Quantification of 
the choroidal vascular density in the inner and outer choroid using the ‘image > adjust > threshold’ window tool of ImageJ to obtain the percentage of vascular 
coverage, obtained from z-stacks collected at ≤ 10 μm or > 10 μm from the outer RPE plane, respectively. (D) Iba1+ and MHC II+ cell number in the choroid in all in- 
depth z-stacks. Images were collected with Zeiss EC Plan-Neofluor 40x oil objective lens, NA 1.3. Quantitative analyses were performed based on 14 independent 
counts per eye in each and all in-depth z-stacks per specimen. Data are expressed as mean ± SEM (n = 7, control group; n = 8, GK group). Scale bar: 50 μm. Sig-
nificance between groups was determined using the independent t-test: *p < 0.05, **p < 0.01. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article). 
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detailed morphological vascular patterns of the CC, since being as thin as 
10− 20 μm, it is not resolved by a system that has a maximum lateral 
resolution within that range (~15− 20 μm), [58] and, as aforemen-
tioned, it is not suitable to evaluated the whole CT. 
Increased choroidal thickness in GK rats might be related to water 
homeostasis and regulation of the extracellular fluid, since the choroidal 
vascular flux has been reported to decrease in diabetes [59,60]. This 
issue is not completed understood yet, but as the water pathway across 
the retina follows a direction from the vitreous to the choroid, one may 
assume that increased VEGF levels and increased capillary permeability 
in the retina, may increase the extracellular fluid in the retina increasing 
the water load on the choroid via a well-functioning RPE [38]. 
Choroidal-dependent retinal drying is modulated by pore regulation of 
the CC, which are mainly facing the RPE side of the CC and are 
VEGF-dependent [57,61]. This water overload is very well pictured in 
OCT when there is impairment of the RPE in DME and subretinal fluid 
accumulates, as a consequence of impairment of the active ionic trans-
port by the RPE [62]. This may explain in part why the choroid thins 
with anti-VEGF administration by intravitreal injections, as a conse-
quence of improved inner BRB homeostasis and decreased water load on 
the choroid [25]. This retina-centered line of thought may be enforced 
by realizing that under anti-VEGF administration pore distribution in 
the CC is reduced, thus decreasing the choroidal-dependent retinal 
drying mechanism [27]. Moreover, the restoration of active ionic 
transport by the RPE, with resolution of subretinal fluid via water flow 
into the choroid, would be expected to thicken and not to thin the 
choroid, as actually happens [62]. 
A most likely explanation for CT decrease with anti-VEGFs is a 
reversible vasoconstriction of the choroidal vessels, as demonstrated in 
the retinal vessels [28,29], under pericyte regulation [55,63]. In the 
choroid, the blood flows in arteries and veins in the same direction, 
contrariwise to most organs. It is possible that some regulation of this 
vascular pathway, namely by pericytes or inflammatory cells, from the 
short posterior ciliary arteries to the vortex veins occurs at different 
levels, including the CC [64]. Perivascular mural cells in the middle and 
outer choroid were previously reported to show contractile properties 
that were related to vasoregulatory functions [55]. Moreover, pericyte 
loss has been reported in GK rats [65], mediated by hypoxia and/or 
inflammation, via vascular endothelial receptor 1 (VEGFR1, Flt-1), nitric 
oxide (NO) and reactive oxygen species (ROS) [63]. 
In addition, VEGF interacts with several vasoactive agents. NO plays 
a critical role in many VEGF actions [66]. Endothelial nitric oxide syn-
thase (eNOS), which is expressed in the CC, regulates the choroidal 
vasculature, since production of NO by this enzyme, causes vasodilation 
[57]. Since there are no true lymphatic vessels in the choroid, a signif-
icant amount of extracellular fluid is reabsorbed via the lamellae of the 
suprachoroid that are under non-vascular smooth muscle cells regula-
tion and are responsive to multiple inflammatory cytokines [12]. 
Increased NO may be involved in decreased extracellular fluid reab-
sorption in the suprachoroid. Apart from vasodilation, NO induces 
increased permeability of pre-terminal choroidal arteries or 
post-capillaries veins, as well [66], despite the reduction of choroidal 
Fig. 3. Microglial cells in the retina and choroid of GK and 
age-matched control Wistar Han rats (52 W). (A) Repre-
sentative eye cross-sections immunolabeled against Iba1 (left 
panels), MHC II (middle panels) and merge (right panels). 
Iba1+ cells are located in the superficial and plexiform layers of 
the retina, mainly. Iba1+ cells located in the OPL of the GK 
cohort only (green arrows). In GK rats, Iba1+ cells migrate from 
the IPL to the OPL, crossing the INL (red arrow). (B) Quanti-
fication of Iba1+ and MHC II+ cell density of GK (n = 8) and 
age-matched control (n = 5) rats based on 12 independent 
specimen counts per eye. Counting was done for the right eye 
only, in all animals. Data are expressed as mean ± SEM. Scale 
bar: 100 μm. Significance between groups was determined 
using the independent t-test: **p < 0.01. GCL, ganglion cell 
layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, 
outer plexiform layer; ONL, outer nuclear layer; RPE, retinal 
pigment epithelium. (For interpretation of the references to 
color in this figure legend, the reader is referred to the web 
version of this article).   
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Fig. 4. Localization of mural and 
endothelial cells in the retina and 
choroid of GK and age-matched 
control Wistar Han rats (52 W). 
(A) Representative eye cross-sections 
immunolabeled against RECA-1 (left 
panels), NG2 (middle panels) and 
merge (right panels). The 3 plexuses 
of the retina are evidenced by RECA-1 
immunostaining (white arrows). 
Communications between (i) the su-
perficial and middle plexuses of the 
retina (red arrow), (ii) the middle and 
deep plexuses and (iii) the deep and 
superficial plexuses (green arrow), 
are visible. RECA-1 immunoreactivity 
relates to the presence of endothelial 
cells and fluorescence of the CC 
endothelial cells is continuous with 
the RPE cell plane (left panels). 
Conversely, NG2 immunostaining of 
pericyte/mural cells leaves focal gaps 
between the RPE and the inner 
choroid, drawing a jagged pattern, 
more pronounced in GK rats (blue 
arrows). (B) Quantification of RECA-1 
and NG2 immunoreactivity in the 
retina and choroid of GK (n = 8) and 
age-matched control (n = 5) rats. 
RECA-1 and NG2 immunoreactivities 
were scored as fluorescence intensity 
per area selected in the choroid 
(reference area selected of 10,737.08 
± 6,306.11 μm2), while NG2+ cells 
and RECA-1 focal immunostaining 
were manually counted in the retina. 
Counting was done for the right eye 
only, in 12 independent specimen 
counts per eye. Data are expressed as 
mean ± SEM. Scale bar: 100 μm. GCL, 
ganglion cell layer; IPL, inner plexi-
form layer; INL, inner nuclear layer; 
OPL, outer plexiform layer; ONL, 
outer nuclear layer; RPE, retinal 
pigment epithelium. (For interpreta-
tion of the references to color in this 
figure legend, the reader is referred to 
the web version of this article).   
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Fig. 5. Immunoreactivity of VEGF and VEGFR2 of GK and age-matched control Wistar Han rats (52 W). (A) Representative eye cross-sections immunolabeled 
against VEGF (left panels), VEGFR2 (middle panels) and merge (right panels). VEGF immunoreactivity spreads throughout the retina, increasing in the OPL, OLM, 
RPE and choroid. VEGFR2 immunoreactivity is higher in the innermost retina (retinal nerve fiber layer) and very low or absent in the RPE and choroid. VEGFR2 
immunoreactivity is still visible as a faint coloration in the retinal layers other than the retinal nerve fiber layer of GK rats only (white arrows). (B) Quantification of 
the VEGF and VEGFR2 immunoreactivity in the retina and choroid of GK rats (n = 8) and age-matched controls (n = 5) based on 12 independent specimen counts per 
eye. VEGF and VEGFR2 immunoreactivities were quantified as fluorescence intensity/area per layer. Counting was done for the right eye only, in all animals. Data 
are expressed as mean ± SEM. Scale bar: 100 μm. Significance between groups was determined using the independent t-test: *p < 0.05. GCL, ganglion cell layer; IPL, 
inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OLM, outer limiting membrane; RPE, retinal 
pigment epithelium. 
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flux in diabetes [60]. Anti-VEGFs counteract all these actions. Further-
more, anti-VEGFs counteract the renin-angiotensin-aldosterone system 
(RAAS) - VEGF crosstalk in the choroid [67], known to have an impor-
tant role in the increased fluid overload present in the pachychoroid 
syndromes and primary aldosteronism [68,69]. RAAS components pre-
sent in retinal cells, in the RPE and the choroid, were shown to be 
involved in the genesis of DME through the proliferation and activation 
of glial cells, expressing angiotensin receptor 1, mineralocorticoid re-
ceptor and aldosterone synthase. These inflammatory events caused by 
increased RAAS activity were amplified by the advanced glycation 
end-products (AGEs), resulting in the release of inflammatory cytokines, 
leading to leukostasis and apoptosis of retinal pericytes. Furthermore, 
RAAS may directly impair the water balance of the retina, acting directly 
on Müller cells, and intravitreal injection of aldosterone causes 
increased CT and leakage from choroidal vessels [70]. 
The assumption that the CT is increased in diabetes and that it de-
creases with anti-VEGFs to a somewhere baseline value is far from being 
consensual [12]. Moreover, HbA1c levels are known to be correlated 
with VEGF levels and inflammation [4,71], but high HbA1c levels have 
been surprisingly correlated with choroidal thinning, and not with the 
expected choroidal thickening [21]. These contradictions address the 
need to be cautious when extrapolating the results of our study to human 
subjects. It would be worth to investigate whether the CT increases in all 
obese animal models of T2D. Since GK rats are a non-obese model of 
T2D, one cannot exclude that this particular feature is characteristic of 
the animal model and not of the disease itself. It is possible that the 
increased CT found may be constitutive of the animal model, expressing 
a more vasodilated basal status of the vasoregulatory mechanisms, a 
feature seen among human subjects as well, expressed by CT 
inter-individual variability [25]. Therefore, it would be useful that in 
future studies other animal models of T2D would be used to compare 
with these results. 
Unfortunately, hitherto OCTA does not detect structures with no 
significant erythrocyte movement, such as the suprachoroid. Therefore, 
it does not add much in the evaluation of the whole CT [50]. This is why 
the binarization technique applied to full CT was also applied to EDI 
OCT, showing no change in CT in diabetes, despite a reduction of the 
subfoveal choroidal vascular index [72]. 
5. Conclusions 
In conclusion, we found an increase in CT, a decrease in inner 
choroidal vascular density, increased Iba1+ cells density in the outer 
retina, and increased VEGFR2 immunoreactivity in the retina, in GK 
rats. Disposition of pericytes and Iba1+ cells in the choroidal stroma 
spare the innermost choroid, either in GK or age-matched control Wistar 
Han rats. 
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[68] M. Zhao, I. Célérier, E. Bousquet, J.-C. Jeanny, L. Jonet, M. Savoldelli, O. Offret, 
A. Curan, N. Farman, F. Jaisser, F. Behar-Cohen, Mineralocorticoid receptor is 
A. Campos et al.                                                                                                                                                                                                                                
Biomedicine & Pharmacotherapy 132 (2020) 110811
11
involved in rat and human ocular chorioretinopathy, J. Clin. Invest. 122 (2012) 
2672–2679, https://doi.org/10.1172/JCI61427. 
[69] E.H.C. van Dijk, M.F. Nijhoff, E.K. de Jong, O.C. Meijer, A.P.J. de Vries, C.J. 
F. Boon, Central serous chorioretinopathy in primary hyperaldosteronism, Graefes 
Arch. Clin. Exp. Ophthalmol. 254 (2016) 2033–2042, https://doi.org/10.1007/ 
s00417-016-3417-8. 
[70] J.L. Wilkinson-Berka, V. Suphapimol, J.R. Jerome, D. Deliyanti, M.J. Allingham, 
Angiotensin II and aldosterone in retinal vasculopathy and inflammation, Exp. Eye 
Res. 187 (2019), 107766, https://doi.org/10.1016/j.exer.2019.107766. 
[71] I.M. Stratton, A.I. Adler, H.A.W. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, 
D. Hadden, R.C. Turner, R.R. Holman, Association of glycaemia with 
macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): 
prospective observational study, BMJ 321 (2000) 405, https://doi.org/10.1136/ 
bmj.321.7258.405. 
[72] K.A. Tan, A. Laude, V. Yip, E. Loo, E.P. Wong, R. Agrawal, Choroidal vascularity 
index - a novel optical coherence tomography parameter for disease monitoring in 
diabetes mellitus? Acta Ophthalmol. 94 (2016) e612–e616, https://doi.org/ 
10.1111/aos.13044. 
A. Campos et al.                                                                                                                                                                                                                                
